INBS
Intelligent Bio Solutions Inc.NASDAQHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$5.44M
P/E Ratio
—
EPS
$-14.87
Beta
4.24
52W High
$24.90
52W Low
$2.29
50-Day MA
$3.32
200-Day MA
$9.17
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Intelligent Bio Solutions Inc.
Intelligent Bio Solutions Inc. (INBS) is an innovative biotechnology firm focused on transforming healthcare through the advancement of diagnostic solutions and biomarker-driven technologies, with a particular emphasis on drug abuse testing and monitoring. Utilizing state-of-the-art scientific methodologies, the company delivers highly accurate, rapid-testing options that enable timely clinical decisions and improve patient outcomes. With its strategic positioning at the intersection of technology and healthcare, INBS is poised to seize opportunities in the expanding market for sophisticated diagnostic tools, thus addressing the increasing demand for more effective healthcare solutions.
Fundamentals
| Revenue (TTM) | $3.58M |
| Gross Profit (TTM) | $1.66M |
| EBITDA | $-9.84M |
| Operating Margin | -290.90% |
| Return on Equity | -150.20% |
| Return on Assets | -51.20% |
| Revenue/Share (TTM) | $4.65 |
| Book Value | $8.96 |
| Price-to-Book | 0.47 |
| Price-to-Sales (TTM) | 1.52 |
| EV/Revenue | 1.796 |
| EV/EBITDA | -0.91 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 47.60% |
| Shares Outstanding | $2.18M |
| Float | $1.54M |
| % Insiders | 3.93% |
| % Institutions | 0.26% |
Historical Volatility
HV 10-Day
53.07%
HV 20-Day
73.39%
HV 30-Day
94.64%
HV 60-Day
83.24%
HV Rank
—
Volatility is currently contracting
More HEALTHCARE Stocks
Data last updated: 5/5/2026